$GKOS
SEC EDGAR Filings Hub
2 Filings
$GKOS · GLAUKOS Corp SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for GLAUKOS Corp ($GKOS) from October 28, 2026 through October 28, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $GKOS portfolio concentration →
View $GKOS Congress trades →
Research $GKOS stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports1
8-K Material Events1
Form 4 Insider0
High-Impact2
Latest FilingOctober 28, 2026
Browse SEC Filings by Form Type
Latest $GKOS SEC Filings & AI Summaries (2)
October 28, 2026
$GKOS 10-Q — GLAUKOS Corp
Glaukos's first-ever GAAP-profitable quarter and 58% revenue growth signal that its next-gen glaucoma and corneal therapies are reaching commercial escape velocity.
October 28, 2026
$GKOS 8-K — GLAUKOS Corp
Glaukos delivered a rare combination of 58% revenue growth, a swing to non-GAAP profitability, a significant guidance raise, and a $1B preliminary 2027 target — all in one release.